Atara Biotherapeutics (ATRA) Cash from Investing Activities (2014 - 2026)
Atara Biotherapeutics' Cash from Investing Activities was -$6.63 million in Q2 2026, compared with -$5.07 million a year earlier.
Powered by 
Analysis
Atara Biotherapeutics (ATRA) Cash from Investing Activities (2014 - 2026) Analysis & Trends
On a trailing twelve-month basis, Atara Biotherapeutics' Cash from Investing Activities was -$607,000 through Jun 30, 2026; for FY2025, it came in at $18.15 million, up 110.4% from FY2024.
- In earlier years, Cash from Investing Activities was $8.62 million in FY2024 (-93.0%), $123.87 million in FY2023 (-39.0%), $202.96 million in FY2022 (+811.8%) and $22.26 million in FY2021.
- The Q2 2026 figure marks the lowest quarterly Cash from Investing Activities since Q3 2024.
- The best year-over-year quarter for Cash from Investing Activities over five years was Q1 2022 (growth of 346.1%); the worst was Q2 2024 (a decline of 85.5%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | -15.40 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | -1.11 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | -1.20 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -5.60 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.11 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -2.91 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | -569.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -10.35 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 2.11 Bn |
| 10 | Atara Biotherapeutics | 142.51 Mn | 132.61 Mn | 439,000.00 | -6.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -6.63 Mn |
| Dec 31, 2025 | 8.44 Mn |
| Sep 30, 2025 | -2.42 Mn |
| Jun 30, 2025 | -5.07 Mn |
| Mar 31, 2025 | 17.20 Mn |
| Dec 31, 2024 | 3.38 Mn |
| Sep 30, 2024 | -16.67 Mn |
| Jun 30, 2024 | 7.20 Mn |
| Mar 31, 2024 | 14.72 Mn |
| Dec 31, 2023 | 9.94 Mn |
| Sep 30, 2023 | 70.45 Mn |
| Jun 30, 2023 | 49.48 Mn |
| Mar 31, 2023 | -6.01 Mn |
| Dec 31, 2022 | 51.22 Mn |
| Sep 30, 2022 | 59.70 Mn |
| Jun 30, 2022 | 31.83 Mn |
| Mar 31, 2022 | 60.22 Mn |
| Dec 31, 2021 | -24.32 Mn |
| Sep 30, 2021 | 1.19 Mn |
| Jun 30, 2021 | 31.89 Mn |
API Access
Atara Biotherapeutics Cash from Investing Activities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=ATRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-from-investing-activities", "ticker": "ATRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=ATRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();